Your browser doesn't support javascript.
No time to waste; the impact of the COVID-19 pandemic on hip, knee, and shoulder arthroplasty surgeries in the Netherlands and Denmark.
Latijnhouwers, Daisy; Pedersen, Alma; Kristiansen, Eskild; Cannegieter, Suzanne; Schreurs, Berend W; van den Hout, Wilbert; Nelissen, Rob; Gademan, Maaike.
  • Latijnhouwers D; Department of Orthopaedics, Leiden University Medical Center, Leiden, the Netherlands.
  • Pedersen A; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
  • Kristiansen E; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Cannegieter S; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
  • Schreurs BW; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
  • van den Hout W; Dutch Arthroplasty Register, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Nelissen R; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.
  • Gademan M; Department of Orthopaedics, Leiden University Medical Center, Leiden, the Netherlands.
Bone Jt Open ; 3(12): 977-990, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2196754
ABSTRACT

AIMS:

This study aimed to investigate the estimated change in primary and revision arthroplasty rate in the Netherlands and Denmark for hips, knees, and shoulders during the COVID-19 pandemic in 2020 (COVID-period). Additional points of focus included the comparison of patient characteristics and hospital type (2019 vs COVID-period), and the estimated loss of quality-adjusted life years (QALYs) and impact on waiting lists.

METHODS:

All hip, knee, and shoulder arthroplasties (2014 to 2020) from the Dutch Arthroplasty Register, and hip and knee arthroplasties from the Danish Hip and Knee Arthroplasty Registries, were included. The expected number of arthroplasties per month in 2020 was estimated using Poisson regression, taking into account changes in age and sex distribution of the general Dutch/Danish population over time, calculating observed/expected (O/E) ratios. Country-specific proportions of patient characteristics and hospital type were calculated per indication category (osteoarthritis/other elective/acute). Waiting list outcomes including QALYs were estimated by modelling virtual waiting lists including 0%, 5% and 10% extra capacity.

RESULTS:

During COVID-period, fewer arthroplasties were performed than expected (Netherlands 20%; Denmark 5%), with the lowest O/E in April. In the Netherlands, more acute indications were prioritized, resulting in more American Society of Anesthesiologists grade III to IV patients receiving surgery. In both countries, no other patient prioritization was present. Relatively more arthroplasties were performed in private hospitals. There were no clinically relevant differences in revision arthroplasties between pre-COVID and COVID-period. Estimated total health loss depending on extra capacity ranged from 19,800 to 29,400 QALYs (Netherlands) 1,700 to 2,400 QALYs (Denmark). With no extra capacity it will take > 30 years to deplete the waiting lists.

CONCLUSION:

The COVID-19 pandemic had an enormous negative effect on arthroplasty rates, but more in the Netherlands than Denmark. In the Netherlands, hip and shoulder patients with acute indications were prioritized. Private hospitals filled in part of the capacity gap. QALY loss due to postponed arthroplasty surgeries is considerable.Cite this article Bone Jt Open 2022;3(12)977-990.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Language: English Journal: Bone Jt Open Year: 2022 Document Type: Article Affiliation country: 2633-1462.312.BJO-2022-0111.R1

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Language: English Journal: Bone Jt Open Year: 2022 Document Type: Article Affiliation country: 2633-1462.312.BJO-2022-0111.R1